Navigation Links
Walgreens Set to Present at CBI's 3rd Forum on Strategic Distribution Planning for Specialty Products
Date:8/23/2012

WOBURN, Mass., Aug. 23, 2012 /PRNewswire/ -- CBI's 3rd Annual Forum on Strategic Distribution for Specialty Products boasts a speaking faculty that includes Todd Grisco, Vice President, Retail Strategy; Anita Dopkosky, Specialty Account Director at Walgreens; and Keith Loehlein, Senior Principal, Supplier Services, IMS.

This September 20–21, attendees will come together with these experts during the in-conference workshop, Optimize a Multi-Channel Approach http://www.cbinet.com/conference/workshop/23828/pc12131, for a deep dive into the intricacies of a multi-channel strategy by exploring which products are best suited to take this direction along with outcomes to date. Attendees will also delve into payer considerations including reimbursement tendencies, options and trends being seen in alternate sites of care.

This workshop at CBI's 3rd Annual Strategic Distribution Planning for Specialty Products kicks off a strong agenda filled with practical experiences and strategies offering top executives involved in channel strategy a roadmap for ensuring pull-through, use and reimbursement of products within this competitive market segment.

The program is being led by Conference Chairman Mike Castagna, Executive Director, Immunoscience Division at Bristol-Myers Squibb. The Industry Keynote Address is being provided by Michael Howe, Senior Director, Trade Relations, at UCB Inc.

About CBI

CBI, an Advanstar company, is the leading provider of market-driven, unbiased conferences for the pharmaceutical, biotechnology, medical device and healthcare industries. CBI offers specialized information presented in interactive formats by thought leaders and regulators.

CONTACT:
Kristina Weljkovic
Phone number: 339-298-2285
Email address: Kristina.weljkovic@cbinet.com

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE The Center for Business Intelligence
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
3. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
4. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
5. Keryx Biopharmaceuticals to Present at The 7th Annual JMP Securities Healthcare Conference
6. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
7. InterMune To Present At JMP Securities Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
9. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
10. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
11. Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
Breaking Biology News(10 mins):